Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Oncology

• Publication date

  2010-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2009.25.0977PMID 20421545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Analysis of Gene Expression Data Using BRB-Array Tools

  2007cited by this paper
• Gene Expression Signatures Predict Outcome in Non–Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study

  2007cited by this paper
• Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.

  2007cited by this paper
• GAzer: gene set analyzer

  2007cited by this paper
• Oncogenic pathway signatures in human cancers as a guide to targeted therapies

  2006cited by this paper
• Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

  2006cited by this paper
• A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

  2006cited by this paper
• Urothelial tumorigenesis: a tale of divergent pathways

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Using the Gene Ontology for Microarray Data Mining: A Comparison of Methods and Application to Age Effects in Human Prefrontal Cortex

  2004cited by this paper
• Focus on bladder cancer.

  2004cited by this paper
• Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling

  2004cited by this paper
• Application of comparative functional genomics to identify best-fit mouse models to study human cancer

  2004cited by this paper
• Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor.

  2004cited by this paper
• Evaluating a New Marker’s Predictive Contribution

  2004cited by this paper
• A random variance model for detection of differential gene expression in small microarray experiments

  2003cited by this paper
• Judging new markers by their ability to improve predictive accuracy.

  2003cited by this paper
• A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

  2003cited by this paper
• Identifying distinct classes of bladder carcinoma using microarrays

  2003cited by this paper
• Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.

  2003cited by this paper
• Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data

  2002cited by this paper
• A Paradigm for Class Prediction Using Gene Expression Profiles

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression.

  2002cited by this paper
• A revised picture of the E2F transcriptional network and RB function.

  2002cited by this paper
• Multiclass cancer diagnosis using tumor gene expression signatures

  2001cited by this paper
• The Rb/E2F pathway and cancer.

  2001cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• Contemporary management of superficial bladder cancer.

  2000cited by this paper
• Recurrence and progression in low grade papillary urothelial tumors.

  1999cited by this paper
• The regulation of E2F by pRB-family proteins.

  1998cited by this paper
• Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53.

  1998cited by this paper
• Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome.

  1997cited by this paper
• Characteristics of invasive bladder cancers: histological and molecular markers.

  1996cited by this paper
• Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment.

  1992cited by this paper
• Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment.

  1992cited by this paper
• Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.

  1991cited by this paper

• Single-cell transcriptomic profiling combined with Mendelian randomization illuminates molecular drivers of bladder cancer

  2026cites this paper
• Interstitial cystitis-related gene CCDC8 accelerates tumorigenesis by participating in CUL7-mediated degradation of P53 in bladder cancer

  2026cites this paper
• Polarity protein Par3 deficiency promotes metastasis of bladder cancer via interaction of Ppp1r12c

  2026cites this paper
• Biomarkers for Recurrence and Prognosis in Metastatic Urothelial Cancer: Emerging Clinical Applications

  2026cites this paper
• RAD54B as a biomarker for prognosis and immunotherapy response in bladder cancer

  2026cites this paper
• Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer

  2025cites this paper
• An unfolded protein response (UPR)-signature regulated by the NFKB–miR-29b/c axis fosters tumor aggressiveness and poor survival in bladder cancer

  2025cites this paper
• Transglutaminase 2 facilitates metastasis of basal-like bladder cancer by sustaining MVP-mediated MAPK/ERK1/2 signaling activation.

  2025cites this paper
• Development of a prognostic model related to mitochondria and programmed cell death-related genes in bladder cancer

  2025cites this paper
• Tumour-infiltrating immune cells as a novel prognostic model for bladder cancer

  2025cites this paper
• Machine learning-driven construction and validation of an intra-tumoral heterogeneity-associated prognostic model for bladder urothelial carcinoma.

  2025cites this paper
• PSMD8 cooperates with USP14 to promote bladder cancer progression by inhibiting ferroptosis

  2025cites this paper
• Therapeutic implications of cancer-associated fibroblast heterogeneity: insights from single-cell and multi-omics analysis

  2025cites this paper
• TRIB3 promotes endometrial cancer progression through interacting with E2F1 and enhancing PKM2-mediated tumor glycolysis.

  2025cites this paper
• Leveraging hypoxia-related genes signature for predicting the prognosis of bladder cancer

  2025cites this paper
• Comprehensive analysis of RNA methylation-related genes to identify molecular cluster for predicting prognosis and immune profiles in bladder cancer

  2025cites this paper
• CancerTrace: Multi-stage single-cell analysis of networked cancer evolution for driver and modulator gene identification

  2025cites this paper
• Emodin Decreases Tumor-Associated Macrophages Accumulation and Suppresses Bladder Cancer Development by Inhibiting CXCL1 Secretion from Cancer-Associated Fibroblasts

  2025cites this paper
• E2F transcription factors as multimodal biomarkers for pan-cancer management

  2025cites this paper
• Machine Learning and Experimental Validation Reveal MYH11 as a Novel Prognostic Biomarker and Therapeutic Target in Bladder Cancer

  2025cites this paper
• Establish TIIC signature score based the machine learning fusion in bladder cancer

  2024cites this paper
• ZDHHC9-mediated Bip/GRP78 S-palmitoylation inhibits unfolded protein response and promotes bladder cancer progression.

  2024cites this paper
• A novel signature constructed by mitochondrial function and cell death-related gene for the prediction of prognosis in bladder cancer

  2024cites this paper
• Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1

  2024cites this paper
• A Multi-Gene Signature of Non-Muscle-Invasive Bladder Cancer Identifies Patients Who Respond to Immunotherapies Including Bacillus Calmette–Guérin and Immune Checkpoint Inhibitors

  2024cites this paper
• Investigating the impact of regulatory B cells and regulatory B cell-related genes on bladder cancer progression and immunotherapeutic sensitivity

  2024cites this paper
• A 23-Gene Prognostic Index Predicts Progression and Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer.

  2024cites this paper
• Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasion

  2024cites this paper
• Identification of bladder cancer subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes

  2024cites this paper
• Molecular biomarkers of progression in non-muscle-invasive bladder cancer — beyond conventional risk stratification

  2024influential citation
• E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer

  2024cites this paper
• Exploration of the prognostic effect of costimulatory genes in bladder cancer

  2024cites this paper
• IGF2BP2 Shapes the Tumor Microenvironment by Regulating Monocyte and Macrophage Recruitment in Bladder Cancer

  2024cites this paper
• Advancing bladder cancer management: development of a prognostic model and personalized therapy

  2024cites this paper
• Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and Benchmark

  2024cites this paper
• Chemoresistance-Motility Signature of Molecular Evolution to Chemotherapy in Non-Muscle-Invasive Bladder Cancer and Its Clinical Implications.

  2024cites this paper
• Identification and validation of prognostic signature genes of bladder cancer by integrating methylation and transcriptomic analysis

  2024cites this paper
• Phosphorus Metabolism-Related Genes Serve as Novel Biomarkers for Predicting Prognosis in Bladder Cancer: A Bioinformatics Analysis

  2024cites this paper
• Orchestrated desaturation reprogramming from stearoyl‐CoA desaturase to fatty acid desaturase 2 in cancer epithelial‐mesenchymal transition and metastasis

  2024cites this paper
• The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma

  2023cites this paper
• Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration

  2023cites this paper
• Procoagulant genes may affect angiogenesis, epithelial-mesenchymal transition, survival prognosis and tumor immune microenvironment in patients with urothelial carcinoma

  2023cites this paper
• The genetic associations of COVID-19 on genitourinary symptoms

  2023cites this paper
• Identification of a cancer-associated fibroblast signature for predicting prognosis and immunotherapeutic responses in bladder urothelial carcinoma

  2023cites this paper
• Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through deregulated microtubule and actin dynamics

  2023cites this paper
• Apoptosis related genes mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide immunotherapy in bladder cancer

  2023cites this paper
• Construction and experimental validation of a B cell-related gene signature to predict the prognosis and immunotherapeutic sensitivity in bladder cancer

  2023cites this paper
• Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer

  2023cites this paper
• Comprehensive analysis of a novel RNA modifications-related model in the prognostic characterization, immune landscape and drug therapy of bladder cancer

  2023cites this paper
• Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation

  2023influential citation
• Expression of HIF-1α/PKM2 axis correlates to biological and clinical significance in papillary thyroid carcinoma

  2023cites this paper
• Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma

  2023cites this paper
• Development and experimental validation of a folate metabolism-related gene signature to predict the prognosis and immunotherapeutic sensitivity in bladder cancer

  2023cites this paper
• Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer

  2022cites this paper
• Association between Arsenic Level, Gene Expression in Asian Population, and In Vitro Carcinogenic Bladder Tumor

  2022influential citation
• TNF Family–Based Signature Predicts Prognosis, Tumor Microenvironment, and Molecular Subtypes in Bladder Carcinoma

  2022influential citation
• KAT2A/E2F1 Promotes Cell Proliferation and Migration via Upregulating the Expression of UBE2C in Pan-Cancer

  2022cites this paper
• Suppression of OCT-1 in Metastatic Breast Cancer Cells Reduces Tumor Metastatic Potential, Hypoxia Resistance, and Drug Resistance

  2022cites this paper
• Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer

  2022influential citation
• Integrative Bioinformatics Analysis of Transcriptomic Data Reveals Hub Genes as Diagnostic Biomarkers for Non-Muscle vs. Muscle Invasive Bladder Cancer

  2022cites this paper
• COL1A1: A novel oncogenic gene and therapeutic target in malignancies.

  2022cites this paper
• An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer

  2022cites this paper
• Characterization of Ligand-Receptor Pair in Bladder Cancer Develops a Validated Scoring Model for Prognosis and Treatment Response

  2022influential citation
• Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy

  2022cites this paper
• Comprehensive Landscape of STEAP Family Members Expression in Human Cancers: Unraveling the Potential Usefulness in Clinical Practice Using Integrated Bioinformatics Analysis

  2022influential citation
• G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors

  2022cites this paper
• YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer

  2022cites this paper
• Interaction between HER2 and ATM predicts poor survival in bladder cancer patients

  2022cites this paper
• Induction of p27 Contributes to Inhibitory Effect of Isorhapontigenin (ISO) on Malignant Transformation of Human Urothelial Cells.

  2022cites this paper
• CircRNAs as Novel Biomarkers and Therapeutic Targets in Renal Cell Carcinoma

  2022cites this paper
• Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes

  2022influential citation
• G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder Cancer

  2022cites this paper
• Fatty Acid Synthase Is the Key Regulator of Fatty Acid Metabolism and Is Related to Immunotherapy in Bladder Cancer

  2022cites this paper
• The miR-532-E2F1 feedback loop contributes to gastric cancer progression

  2022cites this paper
• Toxicogenomics scoring system: TGSS, a novel integrated risk assessment model for chemical carcinogenicity prediction.

  2022cites this paper
• Identification and validation of a novel prognostic model based on platinum resistance-related genes in bladder cancer

  2022influential citation
• The miR-532-E2F1 feedback loop contributes to gastric cancer progression

  2022cites this paper
• Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease

  2022cites this paper
• Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker

  2022influential citation
• Reduced IQGAP2 Promotes Bladder Cancer through Regulation of MAPK/ERK Pathway and Cytokines

  2022cites this paper
• APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases

  2022cites this paper
• Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer

  2022cites this paper
• Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes

  2022cites this paper
• Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay

  2021cites this paper
• ALKBH4 promotes tumourigenesis with a poor prognosis in non-small-cell lung cancer

  2021cites this paper
• Differential Expression Analysis for the Identification of Survival Associated Genes in Primary Bladder Cancer using Microarray Data

  2021cites this paper
• PKM2 is essential for bladder cancer growth and maintenance.

  2021cites this paper
• ENTREP/FAM189A2 encodes a new ITCH ubiquitin ligase activator that is downregulated in breast cancer

  2021cites this paper
• Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer

  2021cites this paper
• Combination Biomarker of Immune Checkpoints Predict Prognosis of Urothelial Carcinoma

  2021cites this paper
• The Long Non-coding RNA TMPO-AS1 Promotes Bladder Cancer Growth and Progression via OTUB1-Induced E2F1 Deubiquitination

  2021cites this paper
• Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder Cancer

  2021cites this paper
• Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer

  2021influential citation
• Gypenoside LI arrests the cell cycle of breast cancer in G0/G1 phase by down-regulating E2F1.

  2021cites this paper
• Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis

  2021cites this paper
• Immune infiltration and prognostic and diagnostic use of LGALS4 in colon adenocarcinoma and bladder urothelial carcinoma

  2021cites this paper
• Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents

  2021cites this paper
• Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses

  2021cites this paper
• Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes

  2021influential citation
• E2F Transcription Factors in Cancer, More than the Cell Cycle

  2021cites this paper